37.2%). Amnioinfusion during labour was not associated with any significant maternal and neonatal complications. The mean hospital stay of the mother was decreased significantly in the study group patients compared to the control group.

Transcervical amnioinfusion in labour for meconium-stained amniotic fluid is a simple, safe and easy-to-perform procedure. It can be performed safely in a setup with limited peripartum https://www.selleckchem.com/products/jph203.html facilities, especially in developing countries, to decrease intrapartum operative intervention and reduce foetomaternal morbidity and mortality.”
“Establishing an effective process to synthesize

anisotropic magnetic nanopowders that have both high energy products and high coercivity is highly desirable for many applications. A recent effort using surfactant-assisted high energy milling ZD1839 ic50 is proved to be capable of making SmCo5 nanoflakes/submicron-flakes with high performance. Using the cast alloy as a starting powder, a series of the flakes with various thicknesses were made, which had energy product values up to 22 MGOe and

coercivity values up to 21 kOe. The highest coercivity corresponds to a typical flake thickness of 180 nm. The key to our technique is retaining the crystallinity, which allows a high degree of anisotropy to be produced. Results of the analyses from the micrograph of SEM, XRD patterns, and magnetic measurements demonstrate the effect of flake thickness on the magnetic properties. More importantly, a relationship of property-morphology correlation in nanoscale is established AZD7762 Cell Cycle inhibitor for rare earth magnetic powder/flakes. (C) 2011 American Institute of Physics. [doi:10.1063/1.3556922]“
“To

evaluate the maternal and perinatal outcome following expectant management of early-onset severe preeclampsia (PE) at a tertiary hospital in Mansoura, Egypt.

This prospective, observational study included 211 patients with severe PE, occurring between 24 and 34 weeks of gestation. They were classified according to gestational age on admission into three groups. Group 1 included 61 patients with gestational ages between 24 and 28 weeks. Group 2 (28 to < 32 weeks) included 66 patients and group 3 (32-34 weeks) included 84 patients. Outcome measures included prolongation of gestation, and maternal and perinatal complications.

The median overall prolongation of gestation was 12 +/- A 6 days. The rate of neonatal survival significantly increased (P < 0.001) from 12/61 (19.7%) in group 1 to 30/66 (45.5%) in group 2 and 67/84 (79.8%) in group 3. There were no maternal mortalities; however, 43 (20.4%) women developed significant morbidities. HELLP syndrome, renal impairment and placental abruption were the main complications.

In low-resource settings, expectant management of early-onset severe PE is associated with relatively higher rates of perinatal mortality and maternal morbidity and should be limited to gestational ages between 28 and 34 weeks of gestation.